B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: VELCADE,Rituximab,Cyclophosphamide and Decadron [Phase 2]
Phase 2 trial update for Velcade in combination with Rituximab, Cyclophosphamide, and Decadron in B-cell non-Hodgkin lymphoma, with terminat…
-
CLINICAL_TRIALS withdrawal · 2013-07-23Clinical Trial Update: Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue [NA]
A clinical trial evaluating armodafinil for patients with B-cell lymphoma and fatigue has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma [Phase 1]
Phase 1 study assessing the safety and tolerability of PCI-32765 (ibrutinib) in patients with recurrent B-cell lymphoma or B-cell leukemia; …
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma [Phase 2]
This update reports the completion of a Phase 2 study of canfosfamide in refractory or relapsed mantle cell lymphoma, B-cell lymphoma, and m…
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide [Phase 1]
Phase 1 trial evaluating Rituximab with Ifosfamide, Carboplatin, and Etoposide for Non-Hodgkin lymphoma has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pralatrexate and gemcitabine with B12 and folic acid in relapsed/refractory lymphoproliferative malignan…
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating PS-341 (bortezomib) alone and with EPOCH chemotherapy for Non-Hodgkin lymphoma; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: Treatment of Mature B-cell Lymphoma/Leukaemia [Phase 3]
Phase 3 clinical trial evaluating treatment for mature B-cell lymphoma has completed. Sponsored by Gustave Roussy/Cancer Campus Grand Paris,…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the safety and preliminary efficacy of SGN-30 (brentuximab vedotin) in patients with CD30-positive …
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma [Phase 1]
Phase 1 trial assessing intratumoral Poly-ICLC with low-dose local radiation in low-grade recurrent B-cell and T-cell lymphomas; the study w…
-
CLINICAL_TRIALS trial_result · 2008-10-27Clinical Trial Update: Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma [Phase 1]
Phase 1 study of L-NDDP (Aroplatin) in patients with advanced solid malignancies or B-cell lymphoma has completed.
-
CLINICAL_TRIALS withdrawal · 2008-09-05Clinical Trial Update: A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma [Phase 1]
This Phase I study evaluating safety and tolerability in adults with lymphoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2006-09-08Clinical Trial Update: Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating Yttrium-90 ibritumomab tiuxetan (Zevalin) with BEAM conditioning in relapsed low-grade B-cell lymphoma has been c…